Serum uric acid and lipid levels while taking topiramate for migraine


KOÇER A. , Dikici S., Atakay S., Okuyucu Ş.

HEADACHE, vol.48, no.7, pp.1056-1060, 2008 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 48 Issue: 7
  • Publication Date: 2008
  • Doi Number: 10.1111/j.1526-4610.2007.01008.x
  • Title of Journal : HEADACHE
  • Page Numbers: pp.1056-1060

Abstract

Objective.-Topiramate (TPM) therapies for epilepsy or migraine are long-time therapies with unknown mechanisms and special side effects. TPM influences cholesterol (TC) and lipoprotein serum levels. In addition, TPM may cause uric acid (UA) stone formation.